Literature DB >> 29123075

Evaluation of the awareness of, attitude to, and knowledge about fertility preservation in cancer patients among clinical practitioners in Hong Kong.

J Pw Chung1, T Th Lao1, T C Li1.   

Abstract

INTRODUCTION: Individuals can be exposed to gonadotoxic agents in the course of treatment for cancers and other medical conditions. Fertility preservation refers to strategies that aim to preserve fertility by protecting it against the damage inflicted by gonadotoxic treatment. Many young patients are prescribed gonadotoxic treatment without prior counselling. This study aimed to study the awareness of, attitude to, and knowledge about fertility preservation among clinicians in Hong Kong.
METHODS: This was a cross-sectional study carried out between June and December 2016 using a self-administered questionnaire. The questionnaires were sent to clinicians in the departments of Clinical Oncology, Haematology, Obstetrics and Gynaecology, Paediatrics, and Surgery in various public hospitals of Hong Kong.
RESULTS: In this survey, 36.5% (167 of 457) of clinicians responded. Of the respondents, only 45.6% were familiar with fertility preservation. The factors considered most important for referral were, in decreasing order of importance, prognosis of the patient, patient's desire to have children, time available before commencing gonadotoxic treatment, type of cancer, and type of gonadotoxic treatment. The majority of clinicians did not refer their patients for fertility preservation due to a lack of available time before treatment, considerable risk of recurrence, poor prognosis, financial constraints, need for cancer treatment as top priority at the time, and lack of awareness of such service. Almost all agreed that a dedicated centre should be set up for fertility preservation and 76.5% agreed that fertility preservation should be provided as a public service.
CONCLUSION: Awareness among clinical practitioners of fertility preservation remains weak. Education of clinicians and the establishment of a dedicated fertility preservation centre are required.

Entities:  

Keywords:  Counseling; Cryopreservation; Neoplasms

Mesh:

Substances:

Year:  2017        PMID: 29123075     DOI: 10.12809/hkmj176840

Source DB:  PubMed          Journal:  Hong Kong Med J        ISSN: 1024-2708            Impact factor:   2.227


  6 in total

1.  Oncofertility: insights from IVF specialists-a worldwide web-based survey analysis.

Authors:  Gon Shoham; Rachel Levy-Toledano; Milton Leong; Ariel Weissman; Yuval Yaron; Zeev Shoham
Journal:  J Assist Reprod Genet       Date:  2019-02-20       Impact factor: 3.412

2.  Lack of Knowledge, the main Stumbling Block of Fertility Preservation Promotion in China.

Authors:  Meng Wang; Lixia Zhu; Hua Xiong; Jiaming Wang; Zhou Li; Liu Yang; Lei Jin; Qingsong Xi
Journal:  J Cancer Educ       Date:  2020-09-12       Impact factor: 1.771

3.  Evaluation of Knowledge, Attitude, and Practice of Health Practitioners towards Fertility Preservation in Cancer Patients in an Environmental Region of Saudi Arabia.

Authors:  Ramya Ahmad Sindi; Marwah Salem Bagabas; Leen Mamdoh Al-Manabre; Raghad Zahi Al-Sofee; Raneem Yousef Rednah; Shrooq Meshal Al-Jahdali
Journal:  J Environ Public Health       Date:  2022-06-06

4.  Fertility preservation in Hong Kong Chinese society: awareness, knowledge and acceptance.

Authors:  Suet Ying Yeung; Elaine Yee Lee Ng; Terence Tzu Hsi Lao; Tin Chiu Li; Jacqueline Pui Wah Chung
Journal:  BMC Womens Health       Date:  2020-04-29       Impact factor: 2.809

5.  The Experience of Fertility Preservation in a Single Tertiary Center in Korea.

Authors:  Yae Ji Choi; Yeon Hee Hong; Seongbeen Kim; Seul Ki Kim; Jung Ryeol Lee; Chang Suk Suh
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-19       Impact factor: 6.055

6.  Knowledge, attitudes, and behaviors of practitioners supporting cancer patients in fertility preservation in DKI Jakarta: A cross-sectional study.

Authors:  Achmad Kemal Harzif; Raymond Surya; Raden Muharam; Gita Pratama; Alfa Putri Meutia
Journal:  Int J Reprod Biomed       Date:  2022-03-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.